arrow
T

Tomoya Isobe

University of Cambridge
H指数:15
被引数:1,100

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Metabolite-induced DNA damage drives stochastic stem cell loss and clonal hematopoiesis

代谢物诱导的DNA损伤驱动随机干细胞丢失和克隆性造血

2026-03-230
OAAI
Comprehensive Molecular and Functional Analysis of NUTM1-Rearranged Leukemia

NUTM1易位白血病的综合分子与功能分析

Blood
IF23.1
2025-12-310
PRE
Multiomics analysis reveals the genetic and epigenetic features of high-risk NK cell–type chronic active EBV infection

多组学分析揭示了高风险NK细胞型慢性活动性EBV感染中的遗传和表观遗传特征

Blood
IF23.1
2025-08-050
PREAI
Clonal hematopoiesis-related mutant ASXL1 promotes atherosclerosis in mice via dysregulated innate immunity
2024-12-090
PRE
Myeloid/natural killer (NK) cell precursor acute leukemia as a distinct leukemia type

骨髓/自然杀伤 (NK) 细胞前体急性白血病是一种独特的白血病类型

2023-12-152
OAAI
Preleukemic single-cell landscapes reveal mutation-specific mechanisms and gene programs predictive of AML patient outcomes
2023-12-011
OAAI
Mitotic perturbation is a key mechanism of action of decitabine in myeloid tumor treatment

有丝分裂扰动是地西他滨治疗髓系肿瘤的关键作用机制

2023-09-014
OA
Identification of the ultrahigh-risk subgroup in neuroblastoma cases through DNA methylation analysis and its treatment exploiting cancer metabolism
2022-11-017
OAAI
Multi-omics analysis defines highly refractory RAS burdened immature subgroup of infant acute lymphoblastic leukemia
2022-08-3014
OAAI
Landscape of driver mutations and their clinical impacts in pediatric B-cell precursor acute lymphoblastic leukemia
2020-10-2336
OAAI
Comprehensive genetic analysis of pediatric germ cell tumors identifies potential drug targets
2020-09-3010
OAAI
Integrated multiomics analysis of hepatoblastoma unravels its heterogeneity and provides novel druggable targets
2020-07-0734
OAAI
DNA methylation-based classification reveals difference between pediatric T-cell acute lymphoblastic leukemia and normal thymocytes
LEUKEMIA
IF13.4
2019-11-1514
PREAI
Integrated Molecular Characterization of the Lethal Pediatric Cancer Pancreatoblastoma
2018-02-1426
OAAI
Recurrent SPI1 (PU.1) fusions in high-risk pediatric T cell acute lymphoblastic leukemia
2017-07-03106
PREAI